Determination of PD‐L1 expression in effusions from mesothelioma by immuno‐cytochemical staining
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Cytopathology"
DOI: 10.1002/cncy.21917
Abstract: Malignant mesothelioma (MM) is an aggressive, fatal tumor. Current therapeutic options only marginally improve survival. Programmed cell death ligand 1 (PD‐L1) is a dominant mediator of immunosuppression, binding to programmed cell death 1 (PD‐1). PD‐L1… read more here.
Keywords: immuno cytochemical; mesothelioma immuno; expression; determination expression ... See more keywords
The cytological features of effusions with mesothelioma in situ: A report of 9 cases
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.25129
Abstract: The diagnosis of mesothelioma in situ (MIS) is now accepted by the WHO as a pre‐invasive neoplastic mesothelial proliferation and considered a diagnosis based on histologic evaluation only. Although the definition of MIS includes recurrent… read more here.
Keywords: report cases; mesothelioma situ; effusions mesothelioma; features effusions ... See more keywords